The effect of low-dose corticosteroids and theophylline on the risk of acute exacerbations of COPD: the TASCS randomised controlled trial

Conclusions
Low-dose theophylline alone or in combination with prednisone did not reduce exacerbation rates or clinically important secondary end-points compared with placebo.

Source: European Respiratory Journal - June 10, 2021 Category: Respiratory Medicine Authors: Jenkins, C. R., Wen, F.-Q., Martin, A., Barnes, P. J., Celli, B., Zhong, N.-S., Zheng, J.-P., Scaria, A., Di Tanna, G.-L., Bradbury, T., Berend, N., on behalf of the TASCS study investigators Tags: COPD and smoking Original Articles: COPD Source Type: research